Just In: Rani Therapeutics Holdings ($RANI) Surge 168% TodayThe price of Rani Therapeutics Holdings, Inc. ( NASDAQ:RANI ) saw a noteworthy uptick of 168% today after market open.
while the asset is still overbought as seen by the RSI at 93, technical metrics shows that should the stock break the ceiling of the 50% Fib level, NASDAQ:RANI will break new highs today.
In recent news, which could be possible catalyst to the recent spike, Rani Therapeutics (NASDAQ: NASDAQ:RANI ), on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's (4519.T), opens new tab experimental antibody, with options to expand to five additional drugs, potentially valuing the deal at $1.09 billion.
About RANI
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies.
